A clinical trial to study the effect of trial drug sundii chooranam on kumbavatham (periarthritis)

A Prospective open labelled non-randomized Phase II Clinical trial on SUNDII CHOORANAM in the management of KUMBA VATHAM (PERI ARTHRITIS)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019142

Enrollment

Registered

2019-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M659- Synovitis and tenosynovitis, unspecified

Interventions

Intervention1: Sundii chooranam: 45mg/kg/BW/twice a day with hot water 45days Control Intervention1: NIL: NIl

Eligibility

Inclusion criteria

Inclusion criteria: Patient having main symptoms of shoulder joint pain restricted movement of upperlimbs loss of abduction and stiffness Diabetes mellitus Willing for doing lab investigation x-ray imaging

Exclusion criteria

Exclusion criteria: Age below 29 and above 61years Rheumatoid arthritis Ischaemic heart disease Hypertension Pregnancy and lactating mother Recent shoulder dislocation Sub acromial bursitis

Design outcomes

Primary

Measure	Time frame
Reduction ot the signs and symptoms of shoulder joint pain restricted movements of the upper limbs loss of abduction and forward flexion and stiffness of shoulder jointTimepoint: 45 days	—

Secondary

Measure	Time frame
Achieving better oxford shoulder score (40-48)Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDR S Justus Antony

Government siddha medical college and hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026